BioCryst Pharmaceuticals
BCRX
#4539
Rank
NZ$4.37 B
Marketcap
NZ$17.23
Share price
1.97%
Change (1 day)
19.28%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$1.43 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is NZ$1.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.75 B-47.16%
2024-12-31NZ$1.43 B9.9%
2023-12-31NZ$1.30 B11.73%
2022-12-31NZ$1.16 B34.46%
2021-12-31NZ$0.86 B124.21%
2020-12-31NZ$0.38 B208.18%
2019-12-31NZ$0.12 B36.38%
2018-12-31NZ$92.16 M19.62%
2017-12-31NZ$77.05 M-0.65%
2016-12-31NZ$77.55 M75.89%
2015-12-31NZ$44.09 M15.16%
2014-12-31NZ$38.28 M4.88%
2013-12-31NZ$36.5 M0.11%
2012-12-31NZ$36.46 M-5.13%
2011-12-31NZ$38.43 M
2000-12-31NZ$0.02 M
1997-12-31NZ$0.17 M-59.42%
1996-12-31NZ$0.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
NZ$38.82 B 2,611.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$44.18 B 2,986.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$1.81 B 26.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.20 B-15.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.51 B-63.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.34 M-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$2.62 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$16.42 M-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.16 B-18.91%๐Ÿ‡บ๐Ÿ‡ธ USA